Summary & Overview
HCPCS Level II E0784: External Ambulatory Insulin Infusion Pump
Headline: HCPCS Level II code E0784 covers external ambulatory insulin infusion pumps
Lead: HCPCS Level II code E0784 designates an external ambulatory infusion pump for insulin delivery. As insulin pumps play an increasing role in diabetes management, this code captures durable medical equipment billed for outpatient and home infusion therapy.
What the code represents and national relevance: HCPCS Level II code E0784 identifies a class of durable medical equipment used to deliver insulin continuously or on demand outside of acute care settings. Insulin pumps can affect glycemic control, reduce complications, and influence durable medical equipment spending patterns, making accurate coding important for clinical care coordination and payer processing nationwide.
Key payers covered: The analysis includes policies and coverage considerations from Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare.
What readers will learn: The publication provides an overview of clinical context for insulin infusion pumps, billing and documentation considerations, common modifiers used with durable medical equipment, related device codes, and payer-specific coverage themes. Benchmarks and policy updates are summarized where available. If specific service-line data or additional inputs are missing, the report notes: "Data not available in the input."
Billing Code Overview
HCPCS Level II code E0784 describes an external ambulatory infusion pump, insulin. This device is categorized under Durable Medical Equipment – Infusion Pumps and is intended to deliver insulin in an outpatient or home setting.
Typical site of service: Durable Medical Equipment supplier (place of service varies).
Data not available in the input for any additional service-line specifics.
Clinical & Coding Specifications
Clinical Context
A patient with insulin-requiring diabetes presents for evaluation of glycemic management and is assessed by an endocrinology or primary care provider. After review of blood glucose records and prior therapy, the clinician determines the patient requires an external ambulatory infusion pump for continuous subcutaneous insulin delivery. The Durable Medical Equipment supplier coordinates coverage verification, selects the HCPCS Level II code E0784 for an external ambulatory infusion pump, and documents medical necessity tied to the patient’s diabetes diagnosis. The supplier provides the pump as new equipment (modifier NU) or as a rental (modifier RR) or documents a used device (modifier UE) if applicable. Training on pump use, infusion set changes, and follow-up plan are provided by the prescribing clinician or diabetes educator, and ongoing claims include the appropriate modifiers and ICD-10 diagnosis linking to the device supply.
Coding Specifications
-
Modifiers:
-
NU: New Equipment — used when the supplier furnishes new durable medical equipment to the patient. -
RR: Rental — used when the supplier is billing for a rental of the equipment rather than purchase. -
UE: Used Equipment — used when the supplier furnishes previously owned equipment to the patient. -
Provider Taxonomies:
-
207RE0101X— Endocrinology, Diabetes & Metabolism Physician: specialty managing complex diabetes care and qualifying documentation for insulin pump therapy. -
207Q00000X— Family Medicine Physician: primary care provider who may prescribe and manage pump therapy. -
207R00000X— Internal Medicine Physician: internist involved in chronic disease management including insulin pump indications.
Related Diagnoses
-
E08.00— Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic‑hyperosmolar coma (NKHHC) -
Clinical relevance: Hyperosmolar hyperglycemic states indicate severe insulin deficiency and potential need for advanced insulin delivery such as an external ambulatory infusion pump to achieve glycemic control.
-
E08.01— Diabetes mellitus due to underlying condition with hyperosmolarity with coma -
Clinical relevance: Represents a severe complication of diabetes where precise insulin delivery and close outpatient management may follow stabilization, and documentation may support need for durable insulin delivery equipment.
-
E08.10— Diabetes mellitus due to underlying condition with ketoacidosis without coma -
Clinical relevance: Diabetic ketoacidosis reflects significant insulin deficiency; after acute management, ongoing insulin delivery options including an external ambulatory infusion pump may be considered and documented for durable medical equipment coverage.
Related Codes
-
E2103— Non‑adjunctive, non‑implanted continuous glucose monitor or receiver (when used with E0784 with integrated glucose sensing) -
Relationship to
E0784: -
E2103may be used when an external ambulatory infusion pump (E0784) includes or is integrated with continuous glucose sensing that provides non‑adjunctive (insulin dosing) glucose data; the CGM or receiver is billed withE2103when appropriate. -
Common usage:
-
E2103is commonly used together withE0784when the pump system includes integrated non‑adjunctive glucose monitoring; otherwiseE0784may be billed withoutE2103.
National Reimbursement Benchmarks
National mean commercial rates for HCPCS Level II code E0784 are generally higher than Medicare-level reimbursement; BUCA (average commercial) mean is $2,060.25 compared with Medicare (no national mean provided in the input). Blue Cross Blue Shield and Cigna Health report the highest mean rates at $2,616.94 and $2,321.25 respectively, while Aetna and UnitedHealthcare report lower means at $1,537.62 and $1,924.27.
Dispersion (P75 minus P25) varies across payers: Blue Cross Blue Shield shows the widest spread ($2,159.67), indicating high variability in paid amounts; BUCA and Aetna show moderate dispersion ($752.91 and $404.07 respectively). Cigna Health is the tightest with no dispersion reported (P75 = P25 = $1,988.33). UnitedHealthcare has a relatively narrow spread ($553.50). The table and chart below present the full breakdown.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.